CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Investor Relations  /  Share Information  /  IEPFA 100 Days Campaign Saksham Niveshak

IEPFA 100 Days Campaign: Saksham Niveshak

Nodal Officer Letter

Newspaper Advertisement

Guidance documents for updating KYC and claiming dividends

Contact information for shareholder support 

Company Contact

E co.secretary@biocon.com

T +91 – (80) – 2808 2808
F +91 – (80) – 2852 3423

Registrar and Transfer Agent Contact

KFin Technologies Limited (Formerly known as KFin Technologies Private Limited)
Selenium Building, Tower-B,
Plot No 31 & 32,Financial District,
Nanakramguda, Serilingampally,
Hyderabad, Rangareddy, Telangana, India – 500 032.

T: 1800 309 4001
E: einward.ris@kfintech.com
RTA Website: https://ris.kfintech.com
Investor Support Centre: https://ris.kfintech.com/clientservices/isc

Know more
about us

>> Key Management Team
>> Generics
>> Syngene

NOVEL BIOLOGICS
BIOSIMILARS
OUR CULTURE
CAREER FAQs
BIOCON FOUNDATION

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2025, Biocon. All Rights Reserved
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>